Author:
Filosso Pier Luigi,Fontana Elisa Carla,Roffinella Matteo
Publisher
Springer International Publishing
Reference69 articles.
1. Travis WD, Brambilla E, Burke AP, et al. WHO classification of tumours of the lung, pleura, thymus and heart. World Health Organization Classification Tumours. 4th ed. Lyon: IARC Press; 2015.
2. Rossi G, Cavazza A, Spagnolo P, Sverzellati N, Longo L, Jukna A, Montanari G, Carbonelli C, Vincenzi G, Bogina G, Franco R, Tiseo M, Cottin V, Colby TV. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome. Eur Respir J. 2016;47:1829–41.
3. Wirtschafter E, Walts AE, Liu ST, Marchevsky AM. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): current best evidence. Lung. 2015;193:659–67.
4. Myint ZW, McCormick J, Chauhan A, Behrens E, Anthony LB. Management of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: review and a single center experience. Lung. 2018 Oct;196(5):577–81.
5. Rindi G, Klersy C, Inzani F, Fellegara G, Ampollini L, Ardizzoni A, Campanini N, Carbognani P, De Pas TM, Galetta D, Granone PL, Righi L, Rusca M, Spaggiari L, Tiseo M, Viale G, Volante M, Papotti M, Pelosi G. Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer. 2013;21:1–16.